Abstract
Assessing quality of life (QoL) is essential in patients with muscular dystrophy where functional improvement is limited. Generic health-related QoL instruments may underestimate patients' well-being by focusing on functional decline, raising questions about how QoL should be understood in those people. The Schedule for the Evaluation of Individual Quality of Life (SEIQoL) offers an individualized approach in which patients identify the life domains that matter most to them and rate their current levels and relative importance in their situations. Changes in domains and weights over time, understood through the concept of response shift, reflect patients' ongoing adaptation rather than mere measurement instability. This paper argues that the clinical value of QoL assessment extends beyond quantification to a dialogical process through which patients and clinicians interpret results together, share values, and shape goals of care.